the overall response rate ( min . 25 % tumor reduction ) was 67/151 ( 44 % ) including four complete remissions in a fairly unfavourable patient group with testicular teratoma ( 39/87 ) , soft tissue sarcoma ( 10/16 ) , malignant melanoma ( 2/7 ) , osteogenic sarcoma ( 3/6 ) , ewing 's sarcoma ( 2/6 ) , lymphoma and acute leukemia ( 5/7 ) or other histologies ( 6/22 ) .
C0029463
osteogenic sarcoma
C0553580
ewing 's sarcoma